With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead ...
Gilead Sciences said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling ...
Stacker on MSN
Achieving lasting remission for HIV
Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, ...
46mon MSN
HIV scare in MP: 4 children test positive; how contaminated blood transfusions can spread the virus
Four thalassemia-affected children aged 12–15 tested HIV positive at a district hospital in Madhya Pradesh, with contaminated ...
Gilead Sciences said on Monday its experimental HIV treatment met the main goal and was found to be statistically ...
News Medical on MSN
Researchers See Dramatic Drop in HIV-Infected Immune Cells in Patient After Cancer Treatment Received
Paper in @jclinicalinvest (bit.ly/497z6jo) by @HopkinsMedicine @JHUMed_ID finds patient living w/ #HIV has dramatic drop in ...
Charlie Sheen reveals an experimental HIV drug that "never made it to market" and discusses his sobriety journey since 2017 ...
When you’re living with HIV, there are a few health markers that your doctor will use to keep track of your care. One of them ...
The tools to stop the spread of HIV are readily available, but experts said they're not getting to the right people.
Howard County will dispense the biannual prevention injection Yeztugo, a less time-consuming option than current preventative ...
As a result, although HIV prevalence is higher among women and girls, the number of AIDS-related deaths is higher among men and boys in the region. Beginning in 2016, Uganda decided to harness the ...
Advancements in HIV/AIDS research, drug development and clinical practice since the 1980s have made it possible for people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results